| Literature DB >> 32625373 |
.
Abstract
According to Article 12(1) of Regulation (EC) No 396/2005, EFSA shall provide within 12 months from the date of the inclusion or non-inclusion of an active substance in Annex I to Directive 91/414/EEC a reasoned opinion on the review of the existing maximum residue levels (MRLs) for that active substance. Among the active substances that need to be reviewed under Article 12(1) of Regulation (EC) No 396/2005, EFSA identified eight active substances for which a review of MRLs is no longer considered necessary. EFSA prepared a statement explaining the reasons why a review of MRLs became obsolete. The relevant question numbers are considered addressed by this statement.Entities:
Keywords: MRLs; Regulation (EC) No 396/2005; active substance; peer review
Year: 2017 PMID: 32625373 PMCID: PMC7010043 DOI: 10.2903/j.efsa.2017.5080
Source DB: PubMed Journal: EFSA J ISSN: 1831-4732
| Question number (MRL review) | Active substance | RMS | Status under Reg (EU) No 1107/2009 | Assessment made by EFSA | MRL Regulation |
|---|---|---|---|---|---|
| EFSA‐Q‐2009‐00021 | Tricyclazole | IT | Not approved | EFSA ( | Commission Regulation (EU) 2017/983 |
| EFSA‐Q‐2015‐00476 | Halauxifen‐methyl | UK | Approved | EFSA ( | Commission Regulation (EU) 2016/67 |
| EFSA‐Q‐2015‐00485 | Sulfoxaflor | IE | Approved | EFSA ( | Commission Regulation (EU) 2016/1, 2017/405 |
| EFSA‐Q‐2015‐00740 | Flumetralin | HU | Approved | EFSA ( | Commission Regulation (EU) 2016/486 |
| EFSA‐Q‐2016‐00116 | 3‐decen‐2‐one | NL | Not approved | EFSA ( | Commission Regulation (EU) 2016/1866 |
| EFSA‐Q‐2016‐00549 | Cyantraniliprole | UK | Approved | EFSA ( | Commission Regulation (EU) 2017/171, 2015/845, 2017/626 |
| EFSA‐Q‐2009‐00094 | Quassia | IT | Not approved | No peer review by EFSA | Regulation (EC) No 396/2005 |
| EFSA‐Q‐2009‐00175 | Methyl nonyl ketone | BE | Not approved | EFSA ( | Annex IV of Regulation (EC) No 396/2005 |
RMS: rapporteur Member State; MRL: maximum residue level.